• By ICR Secretariat
  • Posted Tuesday, November 15, 2022

Galapagos to cut 200 jobs amid research revamp

https://www.biopharmadive.com/news/galapagos-layoffs-job-cuts-restructuring-drug-research/635801/

The workforce reduction is part of a “new strategic direction” for Galapagos, which intends to stop developing drugs for fibrosis and kidney disease.